4/A//SEC Filing
LIGAND PHARMACEUTICALS INC 4/A
Accession 0000899140-07-001143
$LGNDCIK 0000886163operating
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:31 PM ET
Size
5.7 KB
Accession
0000899140-07-001143
Insider Transaction Report
Form 4/AAmended
Perry Jeffrey R
Director
Transactions
- Award
Common Stock
2007-05-31+5,000→ 28,953 total
Footnotes (2)
- [F1]This amendment to Form 4 is being filed by the reporting person to amend and restate the Form 4 filed on June 4, 2007. The original Form 4 incorrectly reported in Table II the type and amount of securities acquired by the reporting person on May 31, 2007. This amendment correctly reports that the reporting person was granted 5,000 shares of restricted common stock, pursuant to the director compensation policy of the issuer, and did not receive a non-qualified stock option to purchase 10,000 shares of common stock, as originally reported. No stock options were granted to the reporting person on May 31, 2007.
- [F2]The shares of restricted common stock will vest on the first anniversary of the date of grant. No price applies.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000886163
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 5:31 PM ET
- Size
- 5.7 KB